Overview
NanoTemper Technologies provides high-quality biophysical characterization instruments for life sciences and pharma research, including Prometheus for stability analysis, Dianthus for affinity screening, and Monolith for molecular interactions. These tools support biologics formulation, developability assessments, protein expression optimization, and challenging targets like membrane proteins and IDPs. Solutions feature technologies such as nanoDSF, DLS, Spectral Shift, MST, and NSM for precise, automation-ready workflows.
Frequently asked questions
- What biophysical characterization capabilities does NanoTemper offer?
- NanoTemper offers stability characterization (nanoDSF, DLS via Prometheus Panta), binding affinity measurements (Spectral Shift, MST via Dianthus and Monolith), protein expression optimization (Andromeda X), and advanced NSM (Dianthus α) for optical unfolding and slow kinetics.
- Which instruments are best for biologics developability and formulation?
- Prometheus Panta combines DLS for particle sizing, nanoDSF for thermal unfolding, and backreflection for aggregation, ideal for biologics formulation optimization, developability, and comparability studies.
- What geographies does NanoTemper serve and any regulatory info?
- NanoTemper operates globally with locations in South San Francisco (USA), Munich (Germany), and Gothenburg (Sweden via acquisition); instruments are designed for high-precision research in pharma/biopharma with no specific regulatory certifications detailed.